Insulet Corp (PODD) Stock Price, Quote & News

Company Profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that...

Industry: Medical Devices

Sector: Healthcare

Phone: 978 600 7000

Website: www.insulet.com

Address:

100 Nagog Park, Acton, United States

QuantInsider Jun. 30 at 4:55 PM

Big move on $PODD today A buyer swept 934 Dec $200 calls at the ask, dropping about $0.86M This is a serious upside bet with a six-month horizon PODD’s been up 3.4% over the last five days but today it’s down nearly 3% Interesting divergence since there’s only call flow, no puts Looks like bullish positioning We need some price stabilization to confirm this dip is bought and not the start of a reversal Keep an eye on how this plays out before jumping in on new shorts

0 · Reply

RocketTrader11 Jun. 30 at 2:42 PM

$PODD https://vistapglobal.com/needles-out-pumps-in-modulars-pivot-and-insulets-omnipod-seek-to-rewrite-the-diabetes-playbook-modd-podd/

0 · Reply

bulltrades1234 Jun. 30 at 1:51 PM

$PODD a little pump followed by a dump

1 · Reply

RocketTrader11 Jun. 29 at 4:55 PM

$PODD https://youtu.be/SaPywoFMBEg?si=fc7z4FTkMiGcwdka

1 · Reply

MODDBlueInMyBlood Jun. 29 at 2:59 PM

$MODD STOP DELETING MY POSTS, YOU SONS OF GUNS. $PODD $TNDM $MDT $ABT I ACTUALLY THINK MODD IS WORTH BEING AQUIRED THIS IS AN ACTUAL PREDICTION WTF IS YOUR PROBLEM DEBATE ME, OR GET OUT OF TOWN.

1 · Reply

PFM88 Jun. 26 at 1:37 PM

$PODD stop buying options… options will push this back down again🥲

1 · Reply

MODDBlueInMyBlood Jun. 24 at 2:23 PM

$MODD $PODD $TNDM $MDT WE GOTTA FIGHT HARD FOR THIS

1 · Reply

RocketTrader11 Jun. 24 at 1:55 PM

$PODD https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/modular-medical-announces-commercial-availability-of-pivot-tubeless-i-1180351

1 · Reply

UpgradeDowngrade Jun. 24 at 11:12 AM

$PODD Deutsche Bank has altered their rating of "Buy" and target of "$190" see consensus outlook

0 · Reply

MODDBlueInMyBlood Jun. 23 at 7:44 PM

$MODD $MDT $PODD $TNDM Screenshot me at your own peril. Holding through the storm 💎 Ill enjoy your screams of agony when the sp doubles

0 · Reply

Insulet to Announce Second Quarter 2026 Financial Results on August 5, 2026

Jun 30, 2026, 7:55 AM EDT - 1 day ago

20 stocks in the S&P 500 that plunged the most in 2026's first half

ACN ADBE BR BSX CRM CSGP CTSH

2026-06-25T11:05:30.000Z - 6 days ago

Insulet appoints Mazelsky to its Board of Directors

Jun 25, 2026, 7:00 AM EDT - 6 days ago

Insulet Announces Appointment of Jonathan J. Mazelsky to its Board of Directors

2026-06-23T16:57:56.000Z - 8 days ago

Insulet initiated with a Buy at Deutsche Bank

2026-06-23T13:18:30.000Z - 8 days ago

Insulet initiated with a Buy at Deutsche Bank

2026-06-11T17:35:58.000Z - 20 days ago

Insulet price target lowered to $219 from $250 at Truist

2026-06-08T19:25:55.000Z - 22 days ago

Insulet price target lowered to $216 from $263 at Raymond James

2026-06-07T21:55:05.000Z - 23 days ago

Insulet announces new results on tubeless AID systems

2026-06-04T18:35:28.000Z - 27 days ago

CDRH issues Early Alert about pump issue from Insulet

2026-06-04T11:08:57.000Z - 27 days ago

Insulet announces planned activities during ADA Scientific Sessions

Jun 4, 2026, 7:00 AM EDT - 27 days ago

Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions

Jun 3, 2026, 3:00 PM EDT - 27 days ago

Insulet Transcript: 46th Annual William Blair Growth Stock Conference

Jun 3, 2026, 3:00 PM EDT - 27 days ago

Insulet Slides: 46th Annual William Blair Growth Stock Conference

2026-06-03T11:35:31.000Z - 4 weeks ago

Insulet announces U.S. rollout of enhanced Omnipod 5 algorithm

Jun 3, 2026, 7:00 AM EDT - 4 weeks ago

Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott's FreeStyle Libre 3 Plus Sensor

2026-05-28T16:25:01.000Z - 4 weeks ago

Insulet court victory over EOFlow reversed on appeal

May 28, 2026, 10:34 AM EDT - 4 weeks ago

US court overturns Insulet's $452 mln insulin-pump trade secret verdict against EOFlow

2026-05-28T12:17:04.000Z - 4 weeks ago

Insulet price target lowered to $165 from $175 at Citi

May 27, 2026, 4:05 PM EDT - 4 weeks ago

Insulet to Participate in William Blair 46th Annual Growth Stock Conference

2026-05-27T12:40:49.000Z - 5 weeks ago

Insulet price target lowered to $205 from $237 at Goldman Sachs

2026-05-26T23:10:09.000Z - 5 weeks ago

Insulet price target lowered to $235 from $260 at BTIG

May 26, 2026, 4:50 PM EDT - 5 weeks ago

Insulet flags dosing defect in some Omnipod devices, sees up to $50 million cost

2026-05-26T20:10:11.000Z - 5 weeks ago

Insulet initiates voluntary medical device correction for certain Omnipod lots

May 26, 2026, 4:05 PM EDT - 5 weeks ago

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected International Markets

May 20, 2026, 10:05 AM EDT - 6 weeks ago

These 15 S&P 500 stocks could be contrarian ways to play the market's uneven rally

APH APP AXON CSGP CVNA EL FICO

May 20, 2026, 8:00 AM EDT - 6 weeks ago

Insulet Transcript: AGM 2026

May 13, 2026, 12:20 PM EDT - 7 weeks ago

Insulet Transcript: Bank of America Global Healthcare Conference 2026

May 6, 2026, 8:00 AM EDT - 2 months ago

Insulet Earnings Call Transcript: Q1 2026

May 6, 2026, 8:00 AM EDT - 2 months ago

Insulet Earnings release: Q1 2026

May 6, 2026, 8:00 AM EDT - 2 months ago

Insulet Slides: Q1 2026

May 6, 2026, 8:00 AM EDT - 2 months ago

Insulet Quarterly report: Q1 2026

May 6, 2026, 7:46 AM EDT - 2 months ago

Insulet lifts annual revenue forecast after quarterly beat on strong insulin pump demand

May 6, 2026, 7:00 AM EDT - 2 months ago

Insulet Reports First Quarter 2026 Results

May 6, 2026, 7:00 AM EDT - 2 months ago

Insulet Slides: Investor presentation

May 5, 2026, 7:00 AM EDT - 2 months ago

Insulet Unveils 2025 Sustainability Report Highlighting Strong Momentum Across Key Priorities

May 5, 2026, 7:00 AM EDT - 2 months ago

Insulet Slides: Omnipod® 5 competitive clinical performance presentation

May 4, 2026, 7:00 AM EDT - 2 months ago

Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes

Apr 28, 2026, 7:00 AM EDT - 2 months ago

Insulet to Participate in BofA Securities 2026 Health Care Conference

Apr 6, 2026, 8:00 AM EDT - 3 months ago

Insulet Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 3 months ago

Insulet Proxy statement: Proxy filing

Apr 1, 2026, 7:00 AM EDT - 3 months ago

Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026

Mar 30, 2026, 8:30 AM EDT - 3 months ago

Insulet Appoints Mike Panos as Chief Commercial Officer

Mar 12, 2026, 5:22 PM EDT - 3 months ago

Insulet recalls some insulin devices in US over leakage risk

Mar 12, 2026, 4:05 PM EDT - 3 months ago

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.

Mar 11, 2026, 4:01 PM EDT - 3 months ago

Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes

Mar 10, 2026, 7:00 AM EDT - 4 months ago

Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

Feb 18, 2026, 8:00 AM EST - 4 months ago

Insulet Earnings Call Transcript: Q4 2025

Feb 18, 2026, 8:00 AM EST - 4 months ago

Insulet Annual report: Q4 2025

Feb 18, 2026, 8:00 AM EST - 4 months ago

Insulet Earnings release: Q4 2025

Feb 18, 2026, 8:00 AM EST - 4 months ago

Insulet Slides: Q4 2025

Feb 18, 2026, 7:55 AM EST - 4 months ago

Insulet beats quarterly estimates on strong demand for wearable insulin pumps

Feb 18, 2026, 7:00 AM EST - 4 months ago

Insulet Reports Fourth Quarter and Full Year 2025 Results

Feb 18, 2026, 7:00 AM EST - 4 months ago

Insulet Slides: Investor presentation

Feb 5, 2026, 7:00 AM EST - 5 months ago

Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care

Jan 19, 2026, 12:41 PM EST - 5 months ago

Is PODD A Better Bet Than ISRG Stock?

ISRG

Jan 13, 2026, 2:15 PM EST - 6 months ago

Insulet Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 2:15 PM EST - 6 months ago

Insulet Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 9, 2026, 6:00 AM EST - 6 months ago

Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026

Jan 6, 2026, 7:00 AM EST - 6 months ago

Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health

Dec 16, 2025, 7:00 AM EST - 7 months ago

Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference

Dec 15, 2025, 7:00 AM EST - 7 months ago

Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future

Dec 11, 2025, 10:37 AM EST - 7 months ago

Eight stock picks to play one of the healthiest corners of the market

ALNY ASND INSM MASI NTRA UNH WGS

Dec 4, 2025, 7:00 AM EST - 7 months ago

Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience

Nov 20, 2025, 12:30 PM EST - 7 months ago

Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day

Nov 20, 2025, 9:00 AM EST - 7 months ago

Insulet Transcript: Investor Day 2025

Nov 20, 2025, 9:00 AM EST - 7 months ago

Insulet Slides: FY 2025

Nov 12, 2025, 2:15 PM EST - 8 months ago

PODD Vs. Intuitive Surgical: This Underdog Might Just Win

ISRG

Nov 6, 2025, 8:00 AM EST - 8 months ago

Insulet Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:00 AM EST - 8 months ago

Insulet Quarterly report: Q3 2025

Nov 6, 2025, 8:00 AM EST - 8 months ago

Insulet Earnings release: Q3 2025

Nov 6, 2025, 8:00 AM EST - 8 months ago

Insulet Slides: Q3 2025

Nov 6, 2025, 7:29 AM EST - 8 months ago

Insulet tops quarterly estimates on demand for wearable insulin pumps

Nov 6, 2025, 6:30 AM EST - 8 months ago

Insulet Reports Third Quarter 2025 Results

Nov 4, 2025, 1:20 PM EST - 8 months ago

Final Trades: Insulet Corp, Uber and Apollo Global

APO UBER

Oct 30, 2025, 4:00 AM EDT - 8 months ago

Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month

Oct 23, 2025, 11:29 AM EDT - 8 months ago

10 stocks primed for growth in the S&P 500's cheapest sectors

BX AJG APO BRO DXCM FITB HOOD

Oct 23, 2025, 7:00 AM EDT - 8 months ago

Insulet Announces Appointment of Robert L. Huffines to its Board of Directors

Oct 10, 2025, 7:00 AM EDT - 9 months ago

Insulet to Host Investor Day on November 20, 2025

Sep 22, 2025, 10:19 AM EDT - 10 months ago

These 15 stocks have beaten the S&P 500 this year — while getting cheaper in the process

ADI BA CCL COIN DASH NUE NVDA

Sep 18, 2025, 7:00 AM EDT - 10 months ago

Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette

Sep 16, 2025, 7:25 AM EDT - 10 months ago

Medical device maker Insulet names industry veteran Flavia Pease as CFO

Sep 16, 2025, 7:00 AM EDT - 10 months ago

Insulet Announces CFO Transition

Sep 9, 2025, 12:15 PM EDT - 10 months ago

Insulet Transcript: Baird Global Healthcare Conference 2025

Sep 9, 2025, 12:15 PM EDT - 10 months ago

Insulet Slides: FY 2025

Sep 4, 2025, 3:00 PM EDT - 10 months ago

Insulet Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Aug 25, 2025, 5:00 PM EDT - 11 months ago

Insulet Elevates Eric Benjamin to Chief Operating Officer

QuantInsider Jun. 30 at 4:55 PM

0 · Reply

RocketTrader11 Jun. 30 at 2:42 PM

$PODD https://vistapglobal.com/needles-out-pumps-in-modulars-pivot-and-insulets-omnipod-seek-to-rewrite-the-diabetes-playbook-modd-podd/

0 · Reply

bulltrades1234 Jun. 30 at 1:51 PM

$PODD a little pump followed by a dump

1 · Reply

RocketTrader11 Jun. 29 at 4:55 PM

$PODD https://youtu.be/SaPywoFMBEg?si=fc7z4FTkMiGcwdka

1 · Reply

MODDBlueInMyBlood Jun. 29 at 2:59 PM

$MODD STOP DELETING MY POSTS, YOU SONS OF GUNS. $PODD $TNDM $MDT $ABT I ACTUALLY THINK MODD IS WORTH BEING AQUIRED THIS IS AN ACTUAL PREDICTION WTF IS YOUR PROBLEM DEBATE ME, OR GET OUT OF TOWN.

1 · Reply

PFM88 Jun. 26 at 1:37 PM

$PODD stop buying options… options will push this back down again🥲

1 · Reply

MODDBlueInMyBlood Jun. 24 at 2:23 PM

$MODD $PODD $TNDM $MDT WE GOTTA FIGHT HARD FOR THIS

1 · Reply

RocketTrader11 Jun. 24 at 1:55 PM

$PODD https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/modular-medical-announces-commercial-availability-of-pivot-tubeless-i-1180351

1 · Reply

UpgradeDowngrade Jun. 24 at 11:12 AM

$PODD Deutsche Bank has altered their rating of "Buy" and target of "$190" see consensus outlook

0 · Reply

MODDBlueInMyBlood Jun. 23 at 7:44 PM

$MODD $MDT $PODD $TNDM Screenshot me at your own peril. Holding through the storm 💎 Ill enjoy your screams of agony when the sp doubles

0 · Reply

theoptionsplug Jun. 23 at 1:54 PM

Top Performers in the S&P 500 so far today: $CDW $AXON $MRNA $PODD

2 · Reply

PFM88 Jun. 22 at 4:36 PM

$PODD new 52 low? It won’t move for a long time until options been cleared out🥲

1 · Reply

ssdsddssd2 Jun. 22 at 3:03 PM

$PODD when its 135 i buy 50s

0 · Reply

MODDBlueInMyBlood Jun. 22 at 12:56 PM

$MODD $PODD $MDT $TNDM FORGET ABOUT THEM. THIS IS OUR WEEK! JUST WAIT FOR HE DAY!

3 · Reply

BioTechHealthX Jun. 21 at 3:17 PM

$PODD Insulet Corporation (PODD) has a 67.59% upside estimate, a $10.18 billion market cap, and new Omnipod 6 data that could reshape the diabetes technology story investors are watching closely. https://biotechhealthx.com/biotech-news/could-insulet-corporation-podd-be-a-smart-long-term-buy-in-healthcare-innovation/

0 · Reply

BioTechHealthX Jun. 21 at 10:05 AM

$ALNY $ONC $BSX $PODD $RYTM Wall Street analysts are spotting major upside in these 10 promising healthcare stocks, including biotech, cancer treatment, diabetes technology, rare disease, and medical device names that could still have serious room to run. https://biotechhealthx.com/biotech-news/top-10-healthcare-stocks-that-could-turn-a-1000-investment-into-something-bigger/

0 · Reply

LinzonTard Jun. 20 at 10:12 PM

$PODD I’m thinking about investing in the pump/CGM space and the field is getting crowded. I think $BBNX wins with simplicity for patients and doctors. It learns dosing itself and meals are not carbohydrate counting, but easy Bolus dosing based on historical learned meals: less, same, more than usual. This will win market share.

1 · Reply

BlowinMaBackOut Jun. 20 at 2:09 PM

$MODD keep in mind $MDT was gonna buy EOFlow for about 730m in 2023...they were just a shitty $PODD knockoff without fda apporval...PODD even beat the piss out of them with a fat lawsuit and the MDT deal fell apart. MODD buyout will be well north of 1b...load the firggin boat you fegs...

0 · Reply

MODDBlueInMyBlood Jun. 19 at 9:09 PM

$MODD $TNDM $PODD $MDT WE NEED TO INVEST MORE IN MODD WE WILL WIN

1 · Reply

NorthstarT1D Jun. 17 at 7:37 PM

$PODD added 5 more shares

1 · Reply

MODDBlueInMyBlood Jun. 16 at 2:14 PM

$MODD $PODD $MDT $TNDM Yeah im a full blown moron. But if thats the case why am I so right 101% of the time? PODD, you are over valued. Just look at the PE. Change your stock ticker from PODD to POO Medtronic, your TPI values are off calibration. Im not explaining that if you dont get it. Tandem you have 5 seconds before i loose my mind. Mag 7 is dead MODD all the way 💎✊️

2 · Reply

PFM88 Jun. 16 at 12:34 AM

$PODD as long as those options there this won’t go anywhere…. Needs a long wait.

0 · Reply

Market Cap	10.93B
Revenue (ttm)	2.71B
Net Income (ttm)	247.10M
EPS (ttm)	N/A
PE Ratio	29.41
Forward PE	24.48
Profit Margin	9.12%
Debt to Equity Ratio	0.73

Volume	745,841
Avg Vol	1,629,570
Day's Range	N/A - N/A
Shares Out	69.27M
Stochastic %K	61%
Beta	1.13
Analysts	Strong Sell
Price Target	$232.40